Methyl 3-(tert-butyl)isoxazole-4-carboxylate

Catalog No.: 
ACFVTH597
CAS No.: 
883032-43-7
Molecular Formula: 
C9H13NO3
Molecular Weight: 
183.21
Methyl 3-(tert-butyl)isoxazole-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$289.00InquiryInquiry
1g97%$723.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-(tert-butyl)isoxazole-4-carboxylate
IUPAC Namemethyl 3-(tert-butyl)isoxazole-4-carboxylate
MDL No.MFCD02090202
Molecular FormulaC9H13NO3
Molecular Weight183.21
SMILESO=C(C1=CON=C1C(C)(C)C)OC
InChI KeyWOGFLCNOPOAMKJ-UHFFFAOYSA-N
Synonymmethyl 3-tert-butylisoxazole-4-carboxylate;4-Isoxazolecarboxylic acid, 3-(1,1-dimethylethyl)-, methyl ester
CAS No.883032-43-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFVTH597 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  4. Then
  5. ACFVTH597 route product structure diagram
    ACFVTH597883032-43-7
Inquiry

2. ACFVTH597 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  4. Then
  5. ACFVTH597 route product structure diagram
    ACFVTH597883032-43-7
Inquiry

3. ACFVTH597 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFVTH597 route product structure diagram
    ACFVTH597883032-43-7
Inquiry

Comments (0)